Literature DB >> 12221675

Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis.

Yossi Cohen1, Gail Amir, Nael Da'as, Shmuel Gillis, Deborah Rund, Aaron Polliack.   

Abstract

This case report deals with an unusual leukostatic complication in a 56-year-old woman with acute myeloblastic leukemia (AML) and extreme hyperleukocytosis (316 x 10(9)/L) who presented with acute myocardial infarction (MI). After leukopheresis the patient achieved hemodynamic stabilization and rapid neurologic recovery of encephalopathy that had also developed after the infarction. Considering the central role of WBC in the remodeling of post MI myocardial tissue, it was obvious that administration of chemotherapy with its subsequent inevitable pancytopenia could impose an increased risk for further cardiac complications including myocardial rupture. Nevertheless, cytarabine-based induction chemotherapy was initiated 3 days after admission, and she achieved prolonged complete remission. Coronary angiography disclosed segmental atherosclerosis, but the only significant obstruction was in the right coronary artery. The patient died with relapsed leukemia 7 years later without recurrence of any cardiac symptoms or signs. Autopsy disclosed segmental coronary atherosclerosis involving the LAD (60% obstruction), suggesting that atherosclerosis was a predisposing risk factor. Additional compromise to blood perfusion due to leukostasis had led to this unusual complication of AML involving a major vessel. This is the first documented case of leukostasis causing coronary artery occlusion as well as the first report of successful induction chemotherapy for AML during a myocardial infarction. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221675     DOI: 10.1002/ajh.10155

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction.

Authors:  Attila Feher; Polydoros N Kampaktsis; Rekha Parameswaran; Eytan M Stein; Richard Steingart; Dipti Gupta
Journal:  Oncologist       Date:  2017-02-03

Review 2.  Lethal limb ischaemia in leukaemia. Case report and review of the literature.

Authors:  Cristina Belizna; Marc Antoine Pistorius; Bernard Planchon
Journal:  J Thromb Thrombolysis       Date:  2008-10-11       Impact factor: 2.300

3.  ST-elevation myocardial infarction and myelodysplastic syndrome with acute myeloid leukemia transformation.

Authors:  Geoffrey T Jao; Mary Ann Knovich; Rodney W Savage; David C Sane
Journal:  Tex Heart Inst J       Date:  2014-04-01

4.  Association between serum amyloid A levels and coronary heart disease: a systematic review and meta-analysis of 26 studies.

Authors:  Jielin Zhou; Yao Lu; Sufang Wang; Keyang Chen
Journal:  Inflamm Res       Date:  2020-02-22       Impact factor: 4.575

5.  Acute Myocardial Infarction as Initial Manifestation of Acute Myeloid Leukemia: A Rare Manifestation of Leukostasis.

Authors:  Dharmini Manogna; Ronald Sham
Journal:  Cureus       Date:  2020-08-04

6.  Cardiac-Related Lesions in Newly Diagnosed Patients With Acute Leukemia: A Chinese Population-Based Real-World Study.

Authors:  Wei Xiao; Linlu Ma; Yufeng Shang; Fuwei Yang; Yuxin Tan; Guopeng Chen; Jinxian Wu; Yuxing Liang; Tuerxunayi Rouzi; Qian Wang; Nan Zhang; Fuling Zhou
Journal:  Front Med (Lausanne)       Date:  2022-06-09

7.  Myocardial Ischemia on MPI SPECT in a Patient with Acute Myeloid Leukemia Without Significant Coronary Artery Disease.

Authors:  Chrissa Sioka; Aris Bechlioulis; Evangelos Ntais; Andreas Fotopoulos; Sotirios Giannopoulos; Eleni Kapsali; Christos Katsouras
Journal:  Mol Imaging Radionucl Ther       Date:  2022-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.